Literature DB >> 15791856

Quantitative assessment of right ventricular systolic function by the analysis of right ventricular contrast time-intensity curve.

Lin Wang1, Youbin Deng, Tianliang Li, Haoyi Yang.   

Abstract

To study reliability and reliable indices of quantitative assessment of right ventricular systolic function by time-intensity curve (TIC) with right ventricular contrast, 5% sonicated human albumin was injected intravenously at a does of 0.08 ml/kg into 10 dogs at baseline status and cardiac insufficiency. Apical four-chamber view was observed for washin and washout of contrast agent from right ventricle. The parameters of TIC were obtained by curve fitting. The differences of parameters were analyzed in different states of cardiac functions. Among the parameters derived from TIC, the time constant (k) was decreased significantly with decline of cardiac function (P<0.001). But half-time of decent of peak intensity (HT) and mean-transit-time (MTT) of washout were increased significantly (P<0.001). The k was strongly related to cardiac output of right ventricle (CO) and ejection fraction (EF) of left ventricle and fractional shortening (FS) of left ventricle. Right ventricular systolic function could be assessed reliably by the parameters derived from TIC with right ventricular contrast echocardiography. The k, HT and MTT are reliable indices for quantitative assessment of right ventricular systolic function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15791856     DOI: 10.1007/BF02911370

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  7 in total

Review 1.  Quantitation of myocardial perfusion with contrast echocardiography.

Authors:  S Kaul
Journal:  Am J Card Imaging       Date:  1991-09

2.  Analysis of regional cerebral blood flow in dogs, with an experimental microbubble-based US contrast agent.

Authors:  R S Greenberg; G A Taylor; J C Stapleton; C A Hillsley; D Spinak
Journal:  Radiology       Date:  1996-10       Impact factor: 11.105

3.  Myocardial perfusion characteristics and hemodynamic profile of MRX-115, a venous echocardiographic contrast agent, during acute myocardial infarction.

Authors:  J R Lindner; C Firschke; K Wei; N C Goodman; D M Skyba; S Kaul
Journal:  J Am Soc Echocardiogr       Date:  1998-01       Impact factor: 5.251

4.  Determination of ejection fraction from contrast echocardiography using videodensitometry in an in vitro model.

Authors:  F Xie; R S Meltzer
Journal:  J Ultrasound Med       Date:  1988-10       Impact factor: 2.153

5.  Ultrasonic backscatter system for automated on-line endocardial boundary detection: evaluation by ultrafast computed tomography.

Authors:  R H Marcus; J Bednarz; R Coulden; S Shroff; M Lipton; R M Lang
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

6.  Assessment of Right Ventricular and Right Atrial Systolic and Diastolic Performance Using Automated Border Detection.

Authors:  Kirk T. Spencer; Maria J. Garcia; Lynn Weinart; Philippe Vignon; Roberto Lang
Journal:  Echocardiography       Date:  1999-10       Impact factor: 1.724

7.  Contrast ultrasonography for 2-D opacification of heart cavities, peripheral vessels, kidney and muscle.

Authors:  A L Strauss; K D Beller
Journal:  Ultrasound Med Biol       Date:  1997       Impact factor: 2.998

  7 in total
  2 in total

1.  Tonglian Decoction () arrests the cell cycle in S-phase by targeting the nuclear factor-kappa B signal pathway in esophageal carcinoma Eca109 cells.

Authors:  Yong-Sen Jia; Xue-Qin Hu; Ji-An Li; Szasz Andras; Gabriella Hegyi; Bing-Sheng Han
Journal:  Chin J Integr Med       Date:  2016-03-05       Impact factor: 1.978

2.  Antitumor Activity of Tenacissoside H on Esophageal Cancer through Arresting Cell Cycle and Regulating PI3K/Akt-NF-κB Transduction Cascade.

Authors:  Yong-Sen Jia; Xue-Qin Hu; Hegyi Gabriella; Li-Juan Qin; Nora Meggyeshazi
Journal:  Evid Based Complement Alternat Med       Date:  2015-09-30       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.